ANTIDIABETIC
Product:
Pozemet
Description:
Pozemet tablet contains two oral antihyperglycemic drugs, pioglitazone hydrochloride and metformin hydrochloride. They are used in the management of type 2 diabetes.
Pioglitazone hydrochloride acts primarily by decreasing insulin resistance. It improves sensitivity to insulin in muscle and adipose tissue and inhibits hepatic gluconeogenesis. It reduces circulating insulin levels and improves glycemic control.
Metformin hydrochloride improves glucose tolerance by lowering both basal and postprandial plasma glucose. It improves insulin sensitivity by increasing peripheral glucose uptake and utilization. It also decreases hepatic glucose production and intestinal absorption of glucose.
Product:
Gluconormet
Description:
Gluconormet is an oral antidiabetic agent (glimepiride & metformin HCl) used in the management of type 2 diabetes.
Glimepiride:
Glimepiride (sulphonylurea class), mechanism of action appears to be dependent on stimulating the release of insulin from functioning pancreatic beta cells.
Metformin HCl:
Metformin improves glucose tolerance in patients with type 2 diabetes, lowering both basal and postprandial plasma glucose.
Product:
Poze
Description:
Poze (pioglitazone hydrochloride) is an oral antidiabetic agent that is used in the management of type 2 diabetes. It acts primarily by decreasing insulin resistance. It improves sensitivity to insulin in muscle and adipose tissue and inhibits hepatic gluconeogenesis. It reduces circulating insulin levels and improves glycemic control.
Product:
Poze G
Description:
Poze G tablets contain two oral antihyperglycemic agents used in the management of type 2 diabetes: pioglitazone hydrochloride and glimepiride.
Pioglitazone hydrochloride acts primarily by decreasing insulin resistance. It improves sensitivity to insulin in muscle and adipose tissue and inhibits hepatic gluconeogenesis. It reduces circulating insulin levels and improves glycemic control.
Glimepiride is an oral glucose-lowering drug of the sulphonylurea class, which acts by increasing the release of insulin from the pancreatic beta cells.
Product:
Gluconorm
Description:
Gluconorm (glimepiride) is an oral blood-glucose-lowering drug of the sulfonylurea class.